New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 8, 2014
04:55 EDTBCR, BCR, ISIS, ISIS, TRVN, TRVN, SGEN, SGEN, ONCS, ONCS, KBIO, KBIO, GNMK, GNMK, LXRX, LXRX, ACAD, ACAD, EXAM, EXAMNeedham to hold a conference
Life Sciences Conference is being held in New York on April 8-9.
News For BCR;ACAD;LXRX;GNMK;KBIO;ONCS;SGEN;TRVN;ISIS;EXAM From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
November 13, 2014
12:05 EDTONCSOncoSec management to meet with Maxim
Meeting to be held in Dallas on November 20 hosted by Maxim.
12:04 EDTONCSOncoSec management to meet with Maxim
Meeting to be held in Chicago on November 17 hosted by Maxim.
05:34 EDTISISAstraZeneca, Isis Pharmaceuticals to co-develop oligonucleotide delivery methods
Subscribe for More Information
November 12, 2014
11:17 EDTSGENLeerink major pharma & biotech analysts hold analyst/industry conference call
Subscribe for More Information
07:53 EDTISIS, SGENLeerink to hold a tour
Subscribe for More Information
November 11, 2014
15:43 EDTSGENLeerink major pharma & biotech analysts hold analyst/industry conference call
Subscribe for More Information
09:13 EDTACADACADIA NDA filing delay minor, says JMP Securities
Subscribe for More Information
07:13 EDTACADACADIA filing delay does not impact price target, says Piper Jaffray
Subscribe for More Information
07:04 EDTTRVNTrevena reports Q3 EPS (59c), consensus (45c)
Subscribe for More Information
November 10, 2014
18:32 EDTACADOn The Fly: After Hours Movers
Subscribe for More Information
16:07 EDTISISIsis Pharmaceuticals files to sell $425M in convertible senior notes due 2021
Subscribe for More Information
16:05 EDTACADACADIA delays NUPLAZID application to Q1 of 2015
ACADIA said it plans to submit its NUPLAZID NDA for Parkinson's disease psychosis in Q1 of 2015. The company had previously planned to submit the NDA near the end of 2014. It stated, "The decision to move back the planned submission is based on additional time required to complete preparations needed to support the U.S. Food and Drug Administrationís, review of NUPLAZID. The change in submission timing is not a result of any change to NUPLAZIDís clinical or safety profile, nor is it a result of any interaction with or request for information from the FDA. Additionally, ACADIA reported that it has successfully completed its drug-drug interaction program and its registration stability program."
16:04 EDTACADACADIA reports Q3 EPS (25c), consensus (22c)
At September 30, 2014, ACADIAís cash, cash equivalents, and investment securities totaled $337.8M.
15:53 EDTSGENCredit Suisse to hold a conference
Healthcare Conference is being held in Scottsdale, Arizona on November 10-13 with webcasted company presentations to begin on November 11 at 10:30 am; not all company presentations may be webcasted. Webcast Link
15:26 EDTACADNotable companies reporting after market close
Subscribe for More Information
November 7, 2014
08:33 EDTISISIsis Pharmaceuticals reports Q3 EPS (23c), consensus (20c)
Subscribe for More Information
07:35 EDTBCRC.R. Bard management to meet with Deutsche Bank
Field trip to company headquarters to be held in Murray Hill, NJ on November 7 hosted by Deutsche Bank.
November 6, 2014
17:02 EDTKBIOKaloBios reports Q3 EPS (24c), consensus (34c)
Subscribe for More Information
15:27 EDTISISNotable companies reporting before tomorrow's open
Notable companies reporting before tomorrow's market open, with earnings consensus, include Humana (HUM), consensus $2.00; Brookfield Asset Management (BAM), one estimate 33c; Magnum Hunter (MHR), consensus (16c); Cooper Tire & Rubber (CTB), consensus 72c; E. W. Scripps (SSP), consensus 6c; Isis Pharmaceuticals (ISIS), consensus (20c); ViaSat (VSAT), consensus 15c; Dresser-Rand (DRC), consensus 63c; Intercept Pharmaceuticals (ICPT), consensus ($1.10).
07:43 EDTISISIsis Pharmaceuticals earns $10M milestone payment from Biogen
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use